Navigation Links
BioElectronics Corporation's Commercial Resumes on Bloomberg Television
Date:7/15/2008

tatements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.

Media Relations Contact:

Patricia Baker, The Big Picture Agency LLC

Voice: 413-623-0950 ext. 221, email: pbaker@bigpictureagency.com

Investor Relations Contact:

Joe Noel, Emerging Growth Research LLP

Voice: 925-922-2560, email: jnoel701@yahoo.com


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
2. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
3. BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11
4. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
5. BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond
6. BioElectronics Corporation Announces New Website for Italian Market
7. Nationally Recognized Corporations and Retailers Rally Behind breastcancer.org
8. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
9. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
10. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
11. OmniGuide Begins European Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 1NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 2NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 3Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 1Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 1President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 4